Novichok: an overview of the world’s deadliest nerve agent
DOI:
https://doi.org/10.18573/bsdj.78Keywords:
Novichok, Nerve Agent, Chemical Weapons, Acetylcholinesterase Inhibitor, Toxicology, NeurologyAbstract
Relevance:
The Novichok class of nerve agents are noxious chemical-weaponized organophosphates. Though its use is prohibited under the 1997 Chemical Weapons Convention, the attempted murder of an ex-Russian spy and his daughter has turned a spotlight on one of the world’s deadliest poisons.
Summary:
Novichok was developed by the Soviet Union in the 1970s and is reportedly ten times more lethal than VX, the nerve agent used to assassinate the half-brother of North Korean leader Kim Jong-un. Novichok produces its toxic effect by irreversibly inhibiting acetylcholinesterase. Unlike other nerve agents, it is thought to target both the central and peripheral nervous systems. Exposure to Novichok invariably leads to death.
Take Home Messages:
With an increase in worldwide chemical weapons usage, including recent use in the United Kingdom, clinicians should know how to rapidly recognize symptoms of nerve agent poisoning, lend their expertise in the education and treatment of such attacks and administer life-saving antidotes.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 The Author(s)Copyright for articles published in the journal is held by The British Student Doctor Journal.
Authors are required to complete a copyright assignment form, available here. The form specifies that authors must seek to obtain permission for publication of any content for which they do not already own the copyright, before submission of the manuscript.
The content of The British Student Doctor Journal is usually made available under a CC-BY-NC-ND 4.0 International (Attribution-NonCommercial-NoDerivatives) licence from Creative Commons. The licence lets others distribute the work in its original form as long as they credit the author(s) of the work.
Authors of articles in The British Student Doctor Journal may request that their work is published under a CC-BY 4.0 (Attribution) licence instead. If this is the case, then please contact the Editor-in-Chief (editorinchief@thesdj.org.uk) at the time of acceptance.
For further information about the licences, please visit https://creativecommons.org/licenses/.
For full details of our open access and copyright policies, then please visit our website.